Evidence map›Paper›PMID 42547887›Full record

ArticleJournal of cheminformatics2026

Transformers for molecular property prediction: domain adaptation efficiently improves performance.

Afnan Sultan, Max Rausch-Dupont, Shahrukh Khan, Olga Kalinina, Dietrich Klakow, Andrea Volkamer

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Afnan SultanData Driven Drug Design, Center for Bioinformatics, PharmaScienceHub (PSH), Saarland University, Universität Campus, 66123, Saarbrücken, Saarland, Germany.
Max Rausch-Dupont *Spoken Language Systems, PharmaScienceHub (PSH), Saarland Informatics Campus, Saarland University, Universität Campus, 66123, Saarbrücken, Saarland, Germany.
Shahrukh KhanSpoken Language Systems, PharmaScienceHub (PSH), Saarland Informatics Campus, Saarland University, Universität Campus, 66123, Saarbrücken, Saarland, Germany.
Olga KalininaDrug Bioinformatics, Center for Bioinformatics, Medical Faculty, PharmaScienceHub (PSH), Saarland University, Saarbrücken, 66123, Saarland, Germany.
Dietrich KlakowSpoken Language Systems, PharmaScienceHub (PSH), Saarland Informatics Campus, Saarland University, Universität Campus, 66123, Saarbrücken, Saarland, Germany. dietrich.klakow@lsv.uni-saarland.de.
Andrea VolkamerData Driven Drug Design, Center for Bioinformatics, PharmaScienceHub (PSH), Saarland University, Universität Campus, 66123, Saarbrücken, Saarland, Germany. Volkamer@cs.uni-saarland.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past six years, molecular transformer models have become a part of the computational toolbox for drug discovery. Most existing models are pre-trained on millions to billions of molecules from large-scale unlabeled datasets such as ZINC or ChEMBL. However, the extent to which such large-scale pre-training improves molecular property prediction remains unclear. This study investigates the potential of transformer models for molecular property prediction while addressing their current limitations. We explore strategies to enhance performance, including the influence of pre-training dataset size and the benefits of domain adaptation through chemically informed objectives. Our results show that increasing the pre-training dataset beyond approximately 400-800K molecules does not improve performance across seven datasets covering five ADME endpoints: lipophilicity, permeability, solubility (two datasets), microsomal stability (two datasets), and plasma protein binding. In contrast, applying domain adaptation on a small number of domain-relevant molecules (

Indexed as

Chemistry-aware modelingDomain adaptationMolecular transformersRigorous analysis

Identifiers

PMID42547887
PMCPMC13430829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.